Ezra, a NYC-based healthcare Artificial Intelligence (AI) company, raised $21M in funding.
The round, which brought the total amount to $41M, was led by Healthier Capital and FirstMark Capital, with participation from Allianz Life Ventures, the Schwarzman family, former Chairman of England’s National Health Service (NHS) Lord David Prior, Gaingels, Republic, Mana Ventures, and existing investors Credo Ventures, Seedcamp, LDV Capital, Accomplice, Founders Future, Vlad Tenev, Anne Wojcicki, and Esther Dyson. Amir Dan Rubin will also join Ezra’s Board of Directors.
The company intends to use the funds to accelerate its expansion to 20 cities and 50 locations across North America in 2024, as well as advance the use of its AI technology by leading imaging centers and clinicians.
Led by Emi Gal, Founder and CEO, Ezra is a healthcare AI company utilizing medical imaging and artificial intelligence to provide individuals with an innovative full body cancer screening service. Founded in 2018, it monitors for possible cancer and 500+ conditions in up to 13 organs, giving individuals the ability to detect potential cancer and other diseases at an earlier stage through preventative, proactive, and ongoing cancer screening via the company’s Full Body MRI scan.
Ezra currently operates at 18 locations across New York, New Jersey, Los Angeles, Irvine, San Francisco, Miami, and Las Vegas.
FinSMEs
08/02/2024